WebTitle: Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers. Journal: Journal of the American College of Cardiology. Name: Victoria Barrios. 4 What is the research question addressed in this study? 5 Identify the dependent variable(s) 5 Identify the independent variable(s) 5 Web17 rows · Among individuals with increased 10-year risk for ASCVD, rosuvastatin 5 mg daily lowered LDL-C ...
Did you know?
Webwith placebo, rosuvastatin administration caused significant decreases in plasma total and LDL cholesterol levels by 24% and 41%, respectively. HDL cholesterol increased by 7%, and serum tri-glyceride levels decreased by 11%. Safety end-points Rosuvastatin was generally well tolerated by all patients. Possible side effects were reported by a WebNov 7, 2024 · Results from a recent study funded by AstraZeneca, called the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study, compared the effects of its prescription low …
WebNov 8, 2024 · The Supplements, Placebo or Rosuvastatin Study (SPORT) was a single-center, prospective, randomized, single-blind trial among designed to compare 6 common dietary supplements, placebo therapy, and low-dose statin therapy for lowering LDL-C in a primary prevention cohort with an LDL-C of 70-189 mg/dL and a 5-20% 10-year risk of … WebNov 7, 2024 · In the current study titled Supplements, Placebo or Rosuvastatin Study (SPORT), researchers analyzed the data of 199 otherwise healthy adults between the ages of 40 and 75 years with no prior...
WebNov 6, 2024 · "What we found was that rosuvastatin lowered LDL cholesterol by almost 38% and that was vastly superior to placebo and any of the six supplements studied in the … WebJan 30, 2024 · The following is a summary of “Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers,” published in the January 2024 issue of Cardiology by Laffin, et al. Supplements were often used by people with lipid-lowering therapeutic reasons.
WebNov 6, 2024 · "What we found was that rosuvastatin lowered LDL cholesterol by almost 38% and that was vastly superior to placebo and any of the six supplements studied in the …
WebApr 14, 2024 · This study showed rosuvastatin reduced LDL levels robustly, but there was not a significantly similar effect among any of the six supplements. The biggest effect was a 7% reduction with red yeast rice, which was not significant compared to placebo. tides friday harborWebDec 17, 2024 · The study’s primary endpoint was the percent change in LDL-C with rosuvastatin compared first to placebo and then to each supplement in a hierarchical fashion (fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice). the magnolia at auburnWebNov 11, 2024 · The supplements tested in the study were fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice. Their effect on LDL was compared to that of rosuvastatin … tides friday harbor wa daiWebThe Supplements, Placebo, or Rosuvastatin Study randomized clinical trial enrolled patients aged 40 to 75 years who had an LDL-C level of 70 to 189 mg/dL, no ASCVD at study entry, and a 10-year ... themagnoliabtqWebNov 7, 2024 · In the SPORT (Supplement, Placebo, or Rosuvastatin Study) trial, the effect of several widely used dietary supplements on lipid and inflammatory biomarkers was investigated. For this prospective, single-center, single-blind RCT, 199 participants were randomized to receive 1 dietary supplement (fish oil, cinnamon, garlic, turmeric, plant … the magnolia at the modernWebIn this double-blind, placebo-controlled clinical study 984 adult patients were randomized (of whom 876 were analyzed) in a 5:2 ratio to rosuvastatin 40 mg or placebo once daily. Ultrasonograms of the carotid walls were used to determine the annualized rate of change per patient from baseline to two years in mean maximum cIMT of 12 measured ... the magnolia brookside kcmoWebNov 7, 2024 · Results from the Supplements, Placebo or Rosuvastatin Study (SPORT) were presented today during a late-breaking science session at the American Heart Association’s Scientific Sessions 2024 and simultaneously published in the Journal of the American College of Cardiology. tides gizmo answer key pdf